fda semaglutide compound ban Compounded is not the same as FDA-approved. The has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before Novo Nordisk asks FDA to

Ozempic injection is approved to: help manage type 2 diabetes in adults lower the risk of serious heart problems in adults who have type 2 diabetes and heart disease lower the risk of worsening kidney disease and death from cardiovascular (heart or blood vessel) disease in adults who have type 2 diabetes and chronic (long-term) kidney disease However, doctors may also prescribe Ozempic off-label for weight loss in: adults and children ages 12 years and older with obesity adults with overweight and at least one weight-related condition, such as high blood pressure or high cholesterol To find out whether Ozempic may be right for you, talk with your doctor

Board-certified dermatologists and plastic surgeons have noted that GLP-1-related weight loss can come with a unique set of skin challenges, including: Facial volume loss: The cheeks, temples, and under-eye area may appear hollowed or deflated as fat pads diminish

Additionally, enrichment related to obesity and pathways associated with multiple CVDs phenotypes, such as coronary artery disease and hypertension, were observed

Multiple clinical trials confirm this with consistent results